Healthcare Law Diagnosis — Transactions Part 2: The role of regulatory due diligence in healthcare and how to prepare for a sell-side transaction (Podcast) – Healthcare


To print this article, all you need to do is be registered or log in to

Diagnosed Health Law Transactions Part 2: Health regulatory due diligence and how to prepare for a sell-side transaction

Health regulatory due diligence has the ability to make or break a deal. Hear our team’s first-hand experience on the importance of exercising health regulatory due diligence and best practices in preparing for a sale transaction.

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

7 Things to Know About the New AdvaMed Code Updates

Sheppard Mullin Richter & Hampton

On March 18, 2022, AdvaMed announced updates to the Code of Ethics for Interactions with Healthcare Professionals (“Code”), a voluntary code that provides medical technology companies…

Food and Beverage Act Update: April 2022

Holland & Knight

In Thornton v. Tyson Foods, Inc., No. 20-2124, 2022 WL 727628 (10th Cir. Mar. 11, 2022), a consumer who purchased beef from retail stores filed a class action lawsuit against meat processors. .


About Author

Comments are closed.